Neutrophil gelatinase-associated lipocalin in idiopathic pulmonary fibrosis

Ikezoe Kohei, Handa Tomohiro, Mori Kiyoshi, Watanabe Kizuku, Tanizawa Kiminobu, Aihara Kensaku, Tsuruyama Tatsuaki, Miyagawa-Hayashino Aya, Sokai Akihiko, Kubo Takeshi, Muro Shigeo, Nagai Sonoko, Hirai Toyohiro, Chin Kazuo, Mishima Michiaki

Source: Eur Respir J 2014; 43: 1807-1809
Journal Issue: June
Disease area: Interstitial lung diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ikezoe Kohei, Handa Tomohiro, Mori Kiyoshi, Watanabe Kizuku, Tanizawa Kiminobu, Aihara Kensaku, Tsuruyama Tatsuaki, Miyagawa-Hayashino Aya, Sokai Akihiko, Kubo Takeshi, Muro Shigeo, Nagai Sonoko, Hirai Toyohiro, Chin Kazuo, Mishima Michiaki. Neutrophil gelatinase-associated lipocalin in idiopathic pulmonary fibrosis. Eur Respir J 2014; 43: 1807-1809

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Neutrophil gelatinase-associated lipocalin (NGAL) is associated with a reduced decline in FVC in male COPD patients
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013


Increased neutrophil gelatinase-associated lipocalin (NGAL) promotes airway remodeling in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

Usefulness of the measurement of plasma neutrophil gelatinase-associated lipocalin as a biomarker for predicting prognosis in hospitalized patients with pneumonia
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018

LSC - 2019 - Neutrophil gelatinase-associated lipocalin and IL-6 – markers predictors for exacerbations in Asthma- COPD overlap, compared to COPD and Asthma
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019


Neutrophil elastase and lung damage in cystic fibrosis
Source: International Congress 2018 – Proteases: at the cutting edge of lung disease
Year: 2018


Neutrophil chemotaxis and adhesion in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2001; 18: Suppl. 33, 108s
Year: 2001

Human neutrophil gelatinase-associated lipocalin: A new biomarker in asthma-COPD overlap syndrome
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016


Neutrophil elastase is necessary for increases in active TGF-β in bleomycin-induced pulmonary fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 199s
Year: 2001

Neutrophil elastase in children with chronic lung diseases
Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects
Year: 2008

A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice
Source: Eur Respir J 2012; 40: 1475-1482
Year: 2012



Neutrophil elastase degraded elastin is elevated in serum of idiopathic pulmonary fibrosis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014


Human neutrophil elastase in acute bronchiolitis
Source: Eur Respir J 2004; 24: Suppl. 48, 24s
Year: 2004

Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis
Source: Eur Respir J 2015; 46: 384-394
Year: 2015



Serum IGFBP2 as a marker of idiopathic pulmonary fibrosis
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015


Expression of macrophage migration inhibitory factor in patients with idiopathic pulmonary fibrosis
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 102s
Year: 2006

Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009


Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


Sputum and plasma neutrophil elastase in stable adult patients with cystic fibrosis in relation to chronic Pseudomonas colonization.
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019


Plasma protein signature of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013